Norepinephrine Dosing and Administration in Septic and Cardiogenic Shock
Initial Dose and Route
Start norepinephrine at 0.02–0.05 µg/kg/min (approximately 0.5 mg/h or 1.4 µg/min for a 70-kg adult) via continuous IV infusion, preferably through central venous access, after administering at least 30 mL/kg crystalloid within the first 3 hours. 1
- The initial dose range of 0.02–0.05 µg/kg/min allows for individualized titration based on the severity of hypotension 1
- Central venous catheter placement is strongly preferred to minimize the risk of extravasation and tissue necrosis 1
- If central access is unavailable, initiate norepinephrine through a large-bore peripheral IV to avoid treatment delays, then transition to central access as soon as feasible 1, 2
Fluid Resuscitation Requirements
- Administer a minimum crystalloid bolus of 30 mL/kg within the first 3 hours (approximately 2 L for a 70-kg adult) before or concurrently with vasopressor initiation 1, 3
- In profound hypotension (SBP < 70 mmHg or DBP ≤ 40 mmHg), start norepinephrine emergently while fluid resuscitation continues rather than delaying for complete volume repletion 1, 4
- Early norepinephrine administration (within 93 minutes of emergency room arrival) significantly increases shock control rates by 6 hours compared to delayed initiation (76.1% vs 48.4%, P < 0.001) 5
Hemodynamic Targets
- Target a minimum MAP of 65 mmHg as the primary endpoint for most patients with septic or cardiogenic shock 1, 3
- In patients with chronic hypertension, consider targeting MAP 70–75 mmHg to reduce the incidence of renal replacement therapy 1
- Monitor blood pressure and heart rate every 5–15 minutes during the initial titration phase 1
- Place an arterial catheter for continuous blood pressure monitoring as soon as practical 6, 1
Monitoring Beyond MAP
MAP alone is insufficient—assess tissue perfusion using lactate clearance (repeat every 2–4 hours), urine output ≥ 0.5 mL/kg/h, mental status, capillary refill ≤ 2 seconds, and skin perfusion. 1, 3
- Lactate clearance provides a dynamic marker of global tissue perfusion and resuscitation adequacy 1
- Urine output ≥ 0.5 mL/kg/h for at least 2 consecutive hours indicates adequate renal perfusion 1
Escalation Strategy for Refractory Hypotension
- When norepinephrine reaches 0.1–0.25 µg/kg/min without achieving MAP ≥ 65 mmHg, add vasopressin at 0.03 units/min as a second-line agent 1, 3
- Do not exceed vasopressin doses of 0.03–0.04 units/min except as salvage therapy, as higher doses cause cardiac, digital, and splanchnic ischemia 6, 1
- If myocardial dysfunction persists despite adequate MAP, add dobutamine at 2.5–20 µg/kg/min to improve cardiac output rather than further escalating vasopressors 1, 2
- For refractory shock after ≥ 4 hours of high-dose vasopressor therapy, administer hydrocortisone 50 mg IV every 6 hours (or 200 mg/day continuous infusion) 1, 3
Agents to Avoid
- Dopamine should not be used as first-line therapy; it is associated with an 11% absolute increase in mortality and significantly higher arrhythmia rates compared to norepinephrine 1, 3
- Low-dose dopamine for renal protection provides no benefit and is strongly discouraged (Grade 1A recommendation) 6, 1
- Phenylephrine should be avoided as first-line therapy because it may raise blood pressure without improving tissue perfusion and can decrease stroke volume 6, 1
Extravasation Management
- If norepinephrine extravasates, immediately infiltrate phentolamine 5–10 mg diluted in 10–15 mL normal saline intradermally at the site to prevent tissue necrosis 1
Special Populations
- In pregnant patients with sepsis, limit the initial fluid bolus to 1–2 L due to higher risk of pulmonary edema, then start norepinephrine at 0.02 µg/kg/min 1
- For pediatric patients, start norepinephrine at 0.1 µg/kg/min, titrating within a range of 0.1–1.0 µg/kg/min, with maximum doses up to 5 µg/kg/min in refractory cases 1
Critical Pitfalls to Avoid
- Do not delay norepinephrine while pursuing aggressive fluid resuscitation alone in severe hypotension (SBP < 70 mmHg or DBP ≤ 40 mmHg), as prolonged hypotension independently worsens mortality 1, 4, 7
- Early norepinephrine administration reduces fluid overload, cardiogenic pulmonary edema (14.4% vs 27.7%, P = 0.004), and new-onset arrhythmias (11% vs 20%, P = 0.03) 5
- Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions, as this inactivates the drug 1